Can anybody thing the possible reason HOVID wanted to take private? There must be something big coming if you trace the information over the past two or three years.
The study for HOVID taking private is getting more interesting and full of surprise. Why TEAL partners working so hard to help HOVID privatization. What do they get from the deal? Only the coming earning from new plant? There is too many questions and it lead to a lot of possible. Even David Ho message is full of clue to the future of HOVID.
BUT RAIDER SAY DO NOT WORRY BCOS WE HAVE LAYOUT DEFENSE LOH....!! OUR STRATEGY IS AS FOLLOWS LOH...!!
1ST DEFENSE APPROCAH, WE TRY TO PREVENT THEM FROM GETTING 75% BY NOT SELLING...IF U HAVE MONIES,U BUY MORE AT RM 0.38. IF THEY FAILED TO GET 75% THEY HAVE NO CHOICE & KEEP HOVID LISTED LOH...!!
2ND DEFENSE APPROACH, EVEN IF THEY MANAGE TO GET 75%...WE STILL CAN PREVENT THEM FOR DELISTING...BY BLOCKING IT LOH..!! SC AS SECUIRITY SAFEGUARD FOR MINORITY AS FOLLOWS, EVEN IF THEY GET 75% LOH.....!! A}THEY NEED TO GET THE NUMBER OF SHARE VOTES IN THEIR FAVOR & PLUS THE SHAREHOLDER VOTES IN THEIR IN THEIR FAVOR LOH...!! B} IF THE MINORITY CAN MUSTER 10% OF SHAREHOLDER AGST THE DELISTING, IT WILL FAIL TOO.
3RD DEFENSE EVEN DELISTING IS SUCCESSFUL...U JUST HAVE TO HOLD ON TO THE PRIVATE CO STOCK OF HOVID AND U STILL CAN PARTICIPATE IN THEIR CORPORATE EXERCISE LOH..!! THE PRIVATE EQUITY FUND & HO FAMILY HAD PUT UP ALOT OF MONIES...THEY WILL NEED TO MAKE THE RELISTING WORK IN ORDER TO MAKE MONIES FOR THEMSELVES, IF U R A SHAREHOLDER U STILL BENEFIT MAH, SO DO NOT WORRY, JUST JOIN THE FUND AND HO FAMILY EVEN ON UNLISTED HOVID LOH...!!
I HOPE BELOW, EXPLAIN THE STRATEGY TO MAKE SURE YOU CAN MAKE MONIES IN A VERY SAFEWAY MAH.....!!
Posted by Wuzy > Dec 22, 2017 04:44 PM | Report Abuse
Czarll 我不清楚干嘛要设67%门槛, 我只知道这个 In the event the Joint Offerors receive acceptances under the Offer resulting in the Join Offerors and their PACs holding more than 75% but less than 90% or where the public shareholdings is 10% or less of the Shares (excluding treasury shares), the Public Spread Requirement will not be met. In this case, the Joint Offerors may procure Hovid to take requisite steps to steps to withdraw its listeing status from Official List of Bursa Securities in accordance with Paragraph 16 of the Listing Requirements. Notwithstanding this, Bursa Securities may at its discretion impose additional conditions for the withdrawal of the Offeree's listing status from the Official List of Bursa Securities.
Posted by PenguinDad > Dec 22, 2017 09:12 PM | Report Abuse
Can anybody thing the possible reason HOVID wanted to take private? There must be something big coming if you trace the information over the past two or three years.
Why Hovid is an acquisition target for potential Big Phama to penetrate Asean & Malaysia Market
Hovid is one of Malaysia’s Top 10 Pharmaceutical Companies In the 1940s, Hovid was birthed when Dr. Ho Kai Cheong created the Chinese Herbal Tea, Ho Yan Hor that has become popular today as a natural beverage to dispel body heat, cure indigestion and relieve common coughs and colds. From its humble beginnings of one core product, the company today produces over 400 products including generic drugs, dietary supplements and consumer products. Harnessing its strength in R&D and the export market, Hovid’s products are distributed to over 50 countries globally. Hovid is the first in the world to develop the commercial scale integrated process for extracting the Palm phytonutrients – carotenes (pro-vitamin A) and tocotrienols (vitamin E) – from locally harvested palm oil and convert them into natural health supplements. Hovid is also an approved supplier to UNICEF and UNRWA. With its facilities and practices conforming to the current Good Manufacturing Practice on the productions, including the halal-certified products, Hovid has evolved into an outstanding industry with excellent quality in both products and services under the leadership of Managing Director, David Ho.
Malaysia’s healthcare system was recently rated as the third best out of 24 countries in the American publication International Living’s 2014 Global Retirement Index. This is due in no small part to the pharmaceutical industry which is divided into two broad streams – home-grown companies that specialises on traditional medicine, food supplements, vitamins, generics and over-the-counter (OTC) drugs; and multinationals which brought in numerous globally tested and accepted quality drugs into the country. Both streams are regulated by the Ministry of Health’s Drug Control Authority (DCA) and together, they help eradicate potentially destructive diseases. New developments such as the production of high-value bio-generics and the potentially lucrative halal drugs market promise an exciting and bright future for this industry. http://top10malaysia.com/main/malaysias-top-10-pharmaceutical-companies/
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Czarll
138 posts
Posted by Czarll > 2017-12-22 17:33 | Report Abuse
daily8 ,21号通告cimb结了20号以前的票为68%。21号公开市场交易了4m unit,为什么刚刚的通告21号只有200k unit?